RE: 40%13 Nov 2025 21:11
Agree with Stas. Nervous from Megrez.
Whist the RNS was neutral, I think it will be worth it in the end. It was clearly done due to Max speaking at the conference today. Speaking at the conference will raise Pantheon’s profile when it comes to future investment and partners. As such, I’m ok with the neutral RNS.
Also, I feel Max speaking in the Financial Times has also looked to raise the companies profile in the US. Especially with the potential US list. He is clearly quietly confident. Who says that they think the Alaskan oil industry is going to see a resurgence and then a few weeks later realer an RNS to say we have a failed flow test. I’m not sure I would want to do that.